Top Ten Common Prejudices About Polyethylene Naphthalate Market.
A central venous catheter, also known as a central line catheter, is a tube that is inserted into a big vein near the heart and is long, thin, and flexible. To give drugs, fluids, nutrition, blood, and blood products, the catheter enters the big vein by the internal jugular vein, subclavian vein, or femoral vein. Furthermore, these catheters are utilised to track Central Venous Pressure (CVP), hemodialysis, and chemotherapy over time.
The market is predicted to develop due to factors such as an increase in the prevalence of cardiovascular illnesses such as atherosclerosis, coronary artery disease, myocardial infarction, and cardiomyopathy, increased awareness of sophisticated technologies, and an increase in the geriatric population. In addition, the market is growing due to an increase in demand for antimicrobial catheters. In rising markets such as Africa, Asia-Pacific, and the Middle East, however, high product costs are projected to constrain the market. During the projection period, R&D in the sector of surgical equipment is expected to provide new opportunities.
Product, property, design, composition, end-user, and geography are all used to segment the central venous catheter market. The market is divided into tunnelled and non-tunneled catheters based on product. The market is divided into antimicrobial and non-antimicrobial catheters based on their properties. The market is divided into three categories: single lumen, double lumen, and multiple lumen. Polyurethane, polycarbonate, and silicon are the three main types of polyurethane. The market is divided into hospitals, ambulatory surgical centres, clinics, and others based on the end-user. It was studied across North America, Europe, Asia-Pacific, and Latin America and the Caribbean.
Furthermore, the increased prevalence of chronic diseases such as cancer, cardiovascular diseases, and chronic kidney disease (CKD) is driving the demand for treatment and care using central venous catheterization, which is likely to fuel market growth. According to WHO data, cancer was the second-leading cause of death globally in February 2018, with roughly 18.1 million new cases and 9.6 million deaths reported. According to the same source, cancer kills roughly 70% of people in low- and middle-income nations, and cancer kills one out of every six people worldwide.
The coronavirus disease (COVID-19) pandemic, which began on December 31, 2019, in Wuhan, China, is the most recent disease outbreak. COVID-19 was declared a pandemic by the World Health Organization on March 11, 2020.
On May 28, 2020, researchers from the Italian organisation GAVeCeLT (Gruppo Accessi Venosi Centrali a Lungo Termine) issued suggestions for COVID-19 patients who need vascular access. The recommendations covered central venous device maintenance, insertion, selection, and development for the operator's safety while treating patients.
Companies in the North American central venous catheter market are concentrating on strategic mergers and acquisitions in order to increase their share of the global central venous catheter market. For example, Bluegrass Vascular Technologies partnered with Merit Medical Systems, a manufacturer and marketer of patented disposable devices, in 2017 to distribute the Surfacer Inside-Out Access Catheter System in Europe.
Comments
Post a Comment